Monthly Archives: May 2008

Dr Reddy’s launches Atocor-R

May 31st, 2008|

Dr. Reddy’s Laboratories, one of India’s top drug makers by sales, has launched Atocor-R (Atorvastatin + Ramipril) in India. 

Logistics – Lifeline of Pharmaceutical Industry

May 30th, 2008|

Today, pharmaceutical, biotechnology and life sciences sectors have emerged as the new hot favorite with the service industry and logistics companies are rushing in to offer tailor-made solutions…[English]-[French]-[Spanish]

Medical tourism flourishes in India

May 28th, 2008|

The attraction of high quality healthcare facilities at competitive costs has been instrumental in a large number of foreign arrivals to access healthcare services in India.

Suven Life Science gets two products` patent

May 28th, 2008|

Suven Life Science received two product patents in Russia and Australia for two of their new chemical entities (NCEs)

Oncolytics Bio gets Canadian patent for cancer tech

May 28th, 2008|

Oncolytics Biotech Inc. has been granted Canadian Patent 2,360,833 entitled "Reovirus for the Treatment of Cellular Proliferative Disorders"

Intas Biopharma to sell lung cancer drug Gefitinib in India

May 28th, 2008|

Intas Biopharmaceuticals is launching lung cancer drug Gefitinib in India and will sell it under ‘Geffy’ brand name.

GVK BIO ties up with Wyeth Pharmaceuticals for Drug Discovery

May 28th, 2008|

GVK BIO has entered into a research agreement with Wyeth Pharmaceuticals, a division of Wyeth to discover drug candidates focused on pre-defined discovery targets.

GTx to continue prostate cancer drug trial

May 28th, 2008|

GTx to continue with the phase III clinical trial evaluating toremifene 20 mg in men with high grade prostatic intraepithelial neoplasia, or PIN, who are at increased risk for prostate cancer should continue as planned following an interim efficacy analysis

Novartis gets EU approval for Extavia

May 28th, 2008|

European Commission has approved Extavia (interferon beta-1b) for the treatment of early and relapsing forms of multiple sclerosis (MS) from Novartis that is planned to include both established treatments and innovative therapies for patients with MS

Dr Reddy’s launches gastritis drug

May 28th, 2008|

Dr Reddy's Laboratories Ltd has launched Omez Insta for patients suffering from acute gastritis and those on Ryle's tube feeding in India.

23rd Exim Bank Annual Commencement Day Lecture

May 27th, 2008|

Emerging South Must Change Global Economic Governance- by – Kemal Dervis, UNDP Administrator…[English-[French]-[Spanish]

Pharmaxis to sell Aridol in Germany

May 23rd, 2008|

Australian pharma major Pharmaxis has been permitted to market Aridol, which is used for measuring airway hyperresponsiveness in Germany.

Gilead Sciences receives US patent for Tenofovir

May 23rd, 2008|

The US Patent & Trademark Office (US PTO) has granted Gilead Sciences the patentability of US Patent No. 6,043,230 for Tenofovir which covers a method of use for Viread (tenofovir disoproxil fumarate).

One-day seminar on quality issues in pharmaceutical by IDMA

May 21st, 2008|

The Quality Management Subcommittee of Indian Drug Manufacturers Association (IDMA) will organise a one-day seminar on 'How quality pays' on May 23, 2008 at Mumbai.

Siemens installs High-Definition PET-CT at Piramal Diagnostics

May 21st, 2008|

Siemens Medical Solutions has installed the high-end PET-CT at Piramal Diagnostics  Mumbai to provide consistently sharper and clearly defined images across the entire field of view.

GlaxoSmithKline flu vaccine Prepandrix gets EU approval

May 21st, 2008|

GlaxoSmithKline (GSK plc) has received a marketing authorization from European Commission for its H5N1 adjuvanted pre-pandemic vaccine, Prepandrix, in all 27 EU member states.

Dabur Pharma gets approval from USFA to sell ‘Mitoxantrone HCL’

May 21st, 2008|

Dabur Pharma Ltd's oncology unit has received the approval from US Food and Drug Administrator (USFDA) for selling 'Mitoxantrone Hydrochloride in various strengths’.

Bayer launches new liquid sargramostim in US

May 21st, 2008|

Bayer HealthCare has launched a reformulation of the liquid Leukine (sargramostim) 500 mcg vial has been approved by the United States Food and Drug Administration (FDA).  Leukine (sargramostim) is a growth factor that helps fight infection and disease in appropriate patients by enhancing immune cell function.

Wyeth launches new anti-depressant in US

May 19th, 2008|

Wyeth Pharmaceuticals has launched pristiq (desvenlafaxine), a new serotonin-norepinephrine reuptake inhibitor (SNRI) in US market.

Lexi-Comp, Inc launches Diagnosis and Disease Management Tool

May 19th, 2008|

Lexi-Comp, Inc., a leading provider of drug reference information, is offering Harrison's Practice a point-of-care diagnostic and patient management tool addressing common diseases and conditions.